AbbVie has issued a request for applications for Independent Medical Education in Chronic Lymphocytic Leukemia (CLL). This program is seeking proposals that will review strategies for effective shared decision-making and highlight why shared decision-making is crucial in CLL treatment selection. Preference will be given to proposals that involve partnerships with academic centers of excellence, regional community practices, known leaders in the field of oncology as well as major professional
societies.
Up to $500,000 will be awarded.
Grant applicants must be US-based, registered in AbbVie’s Grant Management System at grants.abbvie.com with no outstanding reconciliations and authorized to provide accredited CME/CE by an official accrediting agency (e.g. ACCME, AOA, AAFP, AMA, ADA CERP, ANCC, ACPE, etc.).
To Apply:
- This is an open RFP (UCSF may submit an unlimited number of applications).
- Please email [email protected] to announce your intention to apply, then follow application instructions in RFP, conferring with your Grants Officer as needed. Please notify your Grants Officer of your intention to apply as soon as possible to ensure that they will have enough time to support your application.
- Application deadline is December 5, 2025.
For more information and to review complete application instructions and eligibility requirements, please visit https://grants.abbvie.com/AbbVie-RMS-PROD/Docs/AbbVie%20Call%20for%20Concepts%20ONC-CLL%202025%20FINAL.pdf.